Skip to main content
Alan Rodney, MD, Oncology, Webster, TX

AlanJosephRodneyMD

Oncology • Webster, TX

Breast Cancer, Gastrointestinal Cancer, Hematologic Oncology, Thoracic Cancer

Physician

Join to view full profile

Dr. Rodney is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Rodney's full profile

Already have an account?

  • Office

    501 W Medical Center Blvd
    Webster, TX 77598
    Phone+1 281-332-7505
    Fax+1 281-332-7616

Education & Training

  • Baylor College of Medicine
    Baylor College of MedicineFellowship, Hematology, 2005 - 2006
  • University of Texas Health Science Center at Houston/M D Anderson Cancer Center
    University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2003 - 2006
  • Louisiana State University School of Medicine
    Louisiana State University School of MedicineResidency, Internal Medicine, 2000 - 2003
  • Louisiana State University School of Medicine in New Orleans
    Louisiana State University School of Medicine in New OrleansClass of 2000
  • Xavier University of Louisiana
    Xavier University of LouisianaBS, Magna Cum Laude, 1992 - 1996

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2003 - 2025
  • LA State Medical License
    LA State Medical License 2001 - 2003
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Best Oncologist - Friendswood and Pearland TX Living Magazine, 2017
  • Patient�s Choice for Favorite Oncologist Living Magazine, Friendswood and Pearland TX, 2017
  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Ischemic Optic Neuropathy Associated with Low Dose Interferon Alfa: Report of Two Cases  
    A. Rodney, D. Gombos, N. Tannir., American Journal of Clinical Oncology, 1/1/2009
  • Choroidal and Conjunctival Metastases From Renal Cell Carcinoma  
    A. J. Rodney, D. S. Gombos, G. N. Fuller, N. M. Tannir, American Journal of Clinical Oncology, 1/1/2009

Abstracts/Posters

  • Treatment Outcomes of Patients (pts) with Primary Mediastinal Germ Cell Tumors (PMGCT): The M. D. Anderson Cancer Center (MDACC) Experience
    A. J. Rodney, A. Siefker-Radtke, N. M. Tannir, S. Swisher, G. Walsh, R. E. Millikan, L. C. Pagliaro, American Society of Clinical Oncology Annual Meeting Proceedings, 1/1/2006
  • Preliminary Results From a Phase II Study of FOLFIRI Plus Bevacizumab as First-line Treatment for Metastatic Colorectal Cancer (mCRC)
    P. M. Hoff MD, C. Eng, R. B. Adinin, R. A. Wolff, E. Lin, S. Kopetz, A. Rodney, D. Z. Chang, J. L. Abbruzzese, American Society of Clinical Oncology Gastrointestinal Cancers Symposium, 1/1/2006
  • Phase II Study of Capecitabine Combined with Gemcitabine in the Treatment of Androgen-independent Prostate Cancer with Prior Taxane Exposure
    A. Rodney, P. Dieringer, P. Mathew, E. Jonasch, N. Tannir, L. Pagliaro., American Society of Clinical Oncology Annual Meeting Proceedings, 1/1/2005

Press Mentions

  • Get Well Wednesday: Dr. Rodney Answers Your Questions About Blood Clots and More
    Get Well Wednesday: Dr. Rodney Answers Your Questions About Blood Clots and MoreMay 13th, 2015

Dr. Alan Rodney, Dr. Alan Rodney, MD, Dr. A Rodney, Dr. Alan Joseph Rodney